Study determined a 0.8% absolute reduction in "death caused by bleeding" in 20,000 patients.
Absolute increase in mortality if TXA given 3 h after injury TXA treatment given after 3 h after injury was associated with an increased risk of death caused by bleeding (4.4% vs. 3.1%; RR, 1.44; 95% CI, 1.12-1.84; p = 0.004).
The aim of the CRASH-2 trial was to assess the effects of early administration of TXA on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage.
Inclusion criteria include trauma patients judged to be 16 years or older, with significant hemorrhage (SBP < 90 mm Hg and/or heart rate > 110 beats per minute), or considered to be at risk of significant hemorrhage, within 8 hours of injury.
HR, heart rate; IQR, interquartile range; RTS, Revised Trauma Score. 
